Results 201 to 210 of about 45,570 (245)

Cross-kingdom microbial interactions in the gut during inflammatory bowel disease. [PDF]

J Transl Med
Li L, Cai F, Liu Z, Mo W, Zhang J, Qin J, Liang C, Xu H, Liu S, Tang S, Peng P, Liang J, Ruan H, Qin R, Luo F, Xiong G, Yang C, Zou J, Liu S, Geng Y, Huang J.   +20 more
europepmc   +1 more source

Molecular characterisation of Toxoplasma gondii Mre11 reveals unique structural features and potential as a therapeutic target. [PDF]

Sci Rep
Ruiz DM, Turowski VR, Sullivan WJ, Angel SO.   +3 more
europepmc   +1 more source

Insights into the lifecycle of Cryptosporidium and compounds targeting developmental stages. [PDF]

Curr Opin Microbiol
Reynolds Z, Vinayak S.
europepmc   +1 more source

Computational vaccine development against protozoa. [PDF]

Comput Struct Biotechnol J
Hashim O, Dimier-Poisson I.
europepmc   +1 more source

A Multivalent Peptide Vaccine Against Malaria, Targeting Plasmodium Circumsporozoite Protein and Mosquito AgTRIO. [PDF]

J Infect Dis
Chuang YM, Ledizet M, Mattessich M, Fikrig E.   +3 more
europepmc   +1 more source

Nationwide enzooticity of ovine toxoplasmosis and neosporosis in Türkiye. [PDF]

BMC Microbiol
Ceylan O, Sevinc F, Bonkoungou AB, Ceylan C, Yonar H, Ghaibullah MN, Cao S, Xuan X.   +7 more
europepmc   +1 more source

The structural, functional, and therapeutic potential of metacaspases in fungi and protozoa. [PDF]

FEBS J
Duarte ACM, Trujilho MNR, Valdivia KSSM, Araujo AF, de Lorena LMC, de Oliveira VH, Pereira BV, Leme ER, Júdice WAS, Machado MFM.   +9 more
europepmc   +1 more source

Single-cell RNA-seq reveals a key role for <i>Vibrio cholerae</i> Mak toxins in <i>Tetrahymena pyriformis</i> killing and bacterial survival. [PDF]

Front Microbiol
Moon JM, Hoque MM, Ronin D, Noorian P, To J, Rice SA, McDougald D, Espinoza-Vergara G.   +7 more
europepmc   +1 more source

Comparison of a recombinant endonuclease III protein and its synthetic peptides in ELISA for the diagnosis of tegumentary leishmaniasis using human serum and urine samples: A preliminary study. [PDF]

PLoS Negl Trop Dis
Câmara RSB, Abrão DM, Lage DP, Freitas CS, Silva AL, Cardoso MM, Galvani NC, Rodrigues MM, Pimenta BL, Assis BPN, Chaves AT, Tupinambás U, da Costa Rocha MO, Chávez-Fumagalli MA, Machado-de-Ávila RA, Gonçalves DU, Pereira IAG, Coelho EAF, Christodoulides M.   +18 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Using Protozoan Surface Proteins for Effective Oral Vaccination

Trends in Parasitology, 2020
The Global Vaccine Action Plan of the World Health Organization (WHO) calls for nonsyringe delivery mechanisms, thermostable vaccines, and new bioprocessing technologies as priority research areas. Here we discuss the use of protozoan surface proteins to develop a safe, stable, and efficient versatile oral vaccine platform.
Lucia L Rupil
exaly   +3 more sources